Trial Profile
ECARD Combination Tablets LD&HD Special Drug Use Surveillance: Long-term Use (12 Months)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 24 Mar 2022
Price :
$35
*
At a glance
- Drugs Candesartan cilexetil/hydrochlorothiazide (Primary)
- Indications Hypertension
- Focus Adverse reactions
- Sponsors Takeda
- 25 Dec 2013 New trial record